|
... failure of our products to function properly resulting in claims for medical and other losses; ...from time to time in our public releases and reports filed with the Securities and Exchange Commission, ...
01Net
-
10-5-2024
|
|
|
|
Federal Services Segment, such as the Veterans Affairs (VA) Medical Disability Exams (MDE) ... 2023, which was filed with the Securities and Exchange Commission (SEC) on November 16,
01Net
-
9-5-2024
|
|
|
|
... and the initial feedback on our groundbreaking medical device has been overwhelmingly positive. ... Securities and Exchange Commission ('SEC'), including those identified in the 'Risk Factors' section ...
01Net
-
7-5-2024
|
|
|
|
NUBURU's unique high - brightness technology has additional applications in industrial, medical, ...on Form 10 - K or Form 10 - Q and other documents filed with the Securities and Exchange Commission ...
01Net
-
6-5-2024
|
|
|
|
... with approximately 100 clients across multiple markets, processed approximately 29 million medical ...and Current Reports on Form 8 - K filed with or furnished to the Securities and Exchange Commission.
01Net
-
4-5-2024
|
|
|
|
The diverse markets that TurnOnGreen serve include defense and aerospace, medical and healthcare, ... Securities and Exchange Commission, including, but not limited to, the Company's Forms 10 - K, 10 - ...
01Net
-
3-5-2024
|
|
|
|
... industrial production, medical and life sciences, data center computing, networking, and ... Forms 10 - Q and other reports and statements filed with the Securities and Exchange Commission (the 'SEC'). ...
01Net
-
1-5-2024
|
|
|
|
...operations of the Company or its reporting requirements with the Securities and Exchange Commission. Butterfly Network is a digital health company with a mission is to democratize medical imaging by ...
01Net
-
1-5-2024
|
|
|
|
... cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, ...including those detailed from time to time in our filings with the Securities and Exchange Commission.
01Net
-
1-5-2024
|
|
|
|
S., with previous approvals for commercialisation by the European Commission (EC) and National Medical Products Administration (NMPA) in July 2020 and August 2020, respectively. Since its approval in ...
Adnkronos
-
29-4-2024
|
|
|
